Is Melatonin Safe for Daily Use?
Yes, melatonin appears safe for daily use in healthy adults based on current evidence, though long-term safety data beyond 6 months remains limited and quality control of over-the-counter formulations is a significant concern.
Safety Profile Overview
The available evidence consistently demonstrates that melatonin has a favorable short-term safety profile. A 2022 systematic review and meta-analysis of high-dose melatonin (≥10 mg) found no detectable increase in serious adverse events or withdrawals due to adverse effects, though it did show increased risk of mild symptoms like drowsiness, headache, and dizziness 1. A comprehensive 2016 review concluded that both short-term and long-term randomized trials show only mild adverse effects comparable to placebo 2.
Key Safety Considerations
Regulatory Status and Quality Control
A critical caveat is that melatonin is classified as a dietary supplement in the United States and available over-the-counter, meaning no regulatory agency oversees its manufacturing or sale 3. This creates significant variability:
- Melatonin concentration varies widely between product labels and actual content 3
- The U.S. Pharmacopeia Verification Mark indicates verified dosing, which you should look for 4
- In contrast, melatonin requires prescriptions in the European Union and United Kingdom 4
Duration of Use
The most significant limitation in the evidence is the lack of long-term safety data:
- Most studies examine use under 6 months 5
- One review noted that "long-term use appears to benefit certain patient populations" but acknowledged insufficient investigation 3
- Studies at moderate doses (approximately 5-6 mg daily or less) appear safe 3
Metabolic Effects
Recent evidence suggests melatonin may have beneficial metabolic effects rather than harm:
- A 2021 meta-analysis found daily melatonin reduced fasting insulin levels slightly and trended toward reduced insulin resistance 6
- Fasting glucose and HbA1c levels were largely unaffected 6
- This suggests melatonin is glucose-metabolically safe and may even provide benefits 6
Guideline Perspectives
The 2017 American Academy of Sleep Medicine guideline for chronic insomnia found insufficient evidence to determine melatonin's efficacy in chronic insomnia management, though this reflects efficacy rather than safety concerns 7. The British Association for Psychopharmacology recommended prolonged-release melatonin as first-line treatment specifically for insomnia in persons over 55 years 7.
For REM sleep behavior disorder, the 2023 AASM guideline recommends melatonin at 3-15 mg doses, noting it's commonly used in clinical practice with improvements in symptoms 4.
Populations Requiring Caution
Pregnant and breastfeeding women should not take exogenous melatonin due to lack of human studies 2. Potential concerns include:
- Inhibition of reproductive function
- Delayed timing of puberty
- Influence on fetal and neonatal circadian status 5
Young children (aged 0-6 years) represent an emerging concern:
- Melatonin is the leading cause of unsupervised medication exposure and overdose in emergency departments for this age group 8
- Efficacy data are lacking for children with typical development 8
- Long-term outcome data are absent 8
Practical Recommendations
For healthy adults considering daily melatonin:
- Start with low doses (3-6 mg or less) 3
- Look for products with U.S. Pharmacopeia Verification 4
- Be aware that mild side effects (drowsiness, headache, dizziness) may occur 1
- Drug interactions remain virtually unexplored 5
- Avoid use if pregnant, breastfeeding, or have personal/family history of psychiatric disorders 5
The evidence supports melatonin as having a good safety profile for daily use in appropriate populations, but the lack of rigorous long-term studies beyond 6 months and quality control issues with supplements warrant ongoing caution and monitoring 1, 3, 2.